THOUSAND OAKS, Calif. (AP) — THOUSAND OAKS, Calif. (AP) — Atara Biotherapeutics Inc. (ATRA) on Friday reported a loss of $12.7 million in its fourth quarter.
The Thousand Oaks, California-based company said it had a loss of $1.19 per share.
The results topped Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $3.82 per share.
The drug developer posted revenue of $32.8 million in the period.
For the year, the company reported that its loss narrowed to $85.4 million, or $11.41 per share. Revenue was reported as $128.9 million.
Atara Biotherapeutics shares have dropped 48% since the beginning of the year. In the final minutes of trading on Friday, shares hit $6.88, a drop of 60% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ATRA at https://www.zacks.com/ap/ATRA
Copyright © 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
